Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
Trial details
- Registry ID
- NCT00617981
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)NCT00617981 | Imunon | Phase 3 | Completed | 2013-01Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |